Related Experiment Videos
[Thyroid function in patients with alcoholic cirrhosis (author's transl)]
Annales D'Endocrinologie
|March 1, 1980
Summary
Alcoholic cirrhosis alters thyroid function, showing normal thyroxine (T4) but low triiodothyronine (T3) levels. This indicates reduced extrathyroidal conversion and potential hypothalamo-pituitary dysfunction, linked to liver disease severity.
Area of Science:
- Endocrinology
- Hepatology
- Internal Medicine
Context:
- Alcoholic cirrhosis affects multiple organ systems, including the thyroid gland.
- Understanding thyroid status in cirrhosis is crucial for patient management.
- Previous studies have shown variable thyroid function test results in liver disease.
Purpose:
- To determine the thyroid status in men with alcoholic cirrhosis.
- To investigate the relationship between thyroid function tests and liver disease severity.
- To assess hypothalamo-pituitary-thyroid axis function in this population.
Summary:
- Patients with alcoholic cirrhosis exhibited normal total thyroxine (T4) but significantly reduced total triiodothyronine (T3) levels.
- Free thyroxine (FT4) was slightly elevated, while free triiodothyronine (FT3) and reverse T3 (rT3) levels showed decreased and often elevated concentrations, respectively.
- Basal thyrotropin (TSH) levels were slightly elevated, with variable TSH responses to thyrotropin-releasing hormone (TRH), suggesting hypothalamo-pituitary dysfunction.
- Thyroid function tests, particularly T3 and rT3, correlated with liver function markers like serum albumin and a clinical severity index.
- The ratio of rT3 to T3 emerged as a potential indicator of disease severity and prognosis.
Impact:
- The findings highlight a specific pattern of thyroid dysfunction in alcoholic cirrhosis, characterized by altered T4/T3 conversion and hypothalamo-pituitary regulation.
- The study proposes the rT3/T3 ratio as a valuable tool for assessing disease severity and prognosis in alcoholic cirrhosis.
- These insights can contribute to a better understanding of the metabolic consequences of liver disease and inform clinical decision-making.